Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases

被引:4
|
作者
Netzahualcoyotzi, Citlalli [1 ,2 ,5 ]
Santillan-Cigales, Juan Jair [1 ]
Adalid-Peralta, Laura Virginia [2 ]
Velasco, Ivan [1 ,2 ,3 ,4 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City, Mexico
[2] Inst Nacl Neurol & Neurocirugia Manuel Velasco Sua, Lab Reprogramac Celular, Mexico City, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, Mexico
[4] Inst Nacl Neurol & Neurocirugia Manuel Velasco Sua, Lab Reprogramac Celular, Mexico City 14269, Mexico
[5] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Farmacol, Mexico City, Mexico
关键词
Alzheimer's disease; blood-brain barrier; leukocytes; neuroimmunology; neurovascular unit; Parkinson's disease; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PROTEIN; CD8; T-CELLS; ALZHEIMERS-DISEASE; MAST-CELLS; MOUSE MODEL; IFN-GAMMA; BARRIER PERMEABILITY; NEUROVASCULAR UNIT; MICROGLIAL ACTIVATION;
D O I
10.1111/jnc.16106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neurovascular unit, composed of vascular endothelium, vascular smooth muscle, extracellular matrix components, pericytes, astrocytes, microglia, and neurons, allows the highly regulated exchange of molecules and the limited trafficking of cells to the brain through coordinated signaling activity. The passage of peripheral immune cells to the brain parenchyma is observed when there is clear damage to the barriers of this neurovascular unit, as occurs in traumatic brain injury. The possibility of leukocyte infiltration to the brain in neurodegenerative conditions has been proposed. In this review, we focus on describing the evidence for peripheral immune cell infiltration to the brain in the two most frequent neurodegenerative diseases: Alzheimer's and Parkinson's diseases. In particular, we address the mechanisms that promote the passage of these cells into the brain under such pathological conditions. We also discuss the relevance of the resulting cellular interactions, which provide evidence that the presence of peripheral immune cells in the brain is a key point in these neurodegenerative diseases. The disruption of the neurovascular unit and the infiltration of the peripheral immune cells into the central nervous system are hallmarks of neurodegenerative diseases. However, so far, the participation of infiltrating cells in the progression of these diseases has not been completely defined. In this work, we gather the evidence that exists until now which proposes the key events involved in the pathogenesis of the two main neurodegenerative diseases: Alzheimer's and Parkinson's diseases. We detail the alterations in the components that typically keep the neurovascular unit semi-permeable to the cellular interactions that promote a self-perpetuating cycle of inflammation.image
引用
收藏
页码:2316 / 2334
页数:19
相关论文
共 50 条
  • [1] Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
    Prajjwal, Priyadarshi
    Kolanu, Nikhil Deep
    Reddy, Yeruva Bheemeswara
    Ahmed, Aneeqa
    Marsool, Mohammed Dheyaa Marsool
    Santoshi, Krupanagram
    Pattani, Himani Harshad
    John, Jobby
    Chandrasekar, Kiran Kishor
    Hussin, Omniat Amir
    HEALTH SCIENCE REPORTS, 2024, 7 (04)
  • [2] The role of membrane trafficking and retromer complex in Parkinson's and Alzheimer's disease
    Abdul-Rahman, Toufik
    Ghosh, Shankhaneel
    Kalmanovich, Jacob B.
    Awuah, Andrew Wireko
    Zivcevska, Marija
    Khalifa, Samar
    Bassey, Esther Edet
    Ali, Namarig Alnil
    Ferreira, Matheus Mendes dos Santos
    Umar, Tungki Pratama
    Garg, Neil
    Nweze, Victor Nnanna
    Inturu, Venkata Sai Sulekhya
    Abdelwahab, Maya Magdy
    Kurian, Sneha
    Alexiou, Athanasios
    Alfaleh, Mohammed
    Alqurashi, Thamer M. A.
    Ashraf, Ghulam Md
    JOURNAL OF NEUROSCIENCE RESEARCH, 2024, 102 (01)
  • [3] Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases
    Rymbai, Emdormi
    Sugumar, Deepa
    Chakkittukandiyil, Amritha
    Kothandan, Ram
    Selvaraj, Divakar
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (03)
  • [4] Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy
    Nohesara, Shabnam
    Abdolmaleky, Hamid Mostafavi
    Thiagalingam, Sam
    Zhou, Jin-Rong
    EPIGENOMICS, 2024, 16 (01) : 57 - 77
  • [5] A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease
    Ghosh, Nabanita
    Sinha, Krishnendu
    Sil, Parames C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 134 (05) : 602 - 613
  • [6] Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: molecular mechanisms, biomarkers, diagnosis, and therapies, volume III
    Jiang, Jiehui
    Shi, Kuangyu
    Hettie, Kenneth S.
    Hsu, Chih-Yu
    Kung, Woon-Man
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 15
  • [7] Deep Brain Stimulation for Parkinson's Disease-the Developing World's Perspective
    Patel, Khushboo
    Puthanveedu, Divya Kalikavil
    Vijayaraghavan, Asish
    Kesavapisharady, Krishnakumar
    Sarma, Gangadhara
    Sarma, Sankara P.
    Krishnan, Syam
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (12): : 1750 - 1758
  • [8] Memantine's double duty? Investigating its impact on epilepsy control in Alzheimer's disease
    Rayala, Harika
    Kapur, Jaideep
    El-Haija, Hiba Abu
    Parikh, Prachi
    Zawar, Ifrah
    EPILEPTIC DISORDERS, 2024, 26 (02) : 261 - 263
  • [9] Parkinson's Disease Psychosis and the Marketing of Pimavanserin
    Daeschler, Daisy
    Fugh-Berman, Adriane
    INTERNATIONAL JOURNAL OF SOCIAL DETERMINANTS OF HEALTH AND HEALTH SERVICES, 2024, : 272 - 284
  • [10] New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshop
    Telpoukhovskaia, Maria A.
    Murdy, Thomas J.
    Marola, Olivia J.
    Charland, Kevin
    Maclean, Michael
    Luquez, Tain
    Lish, Alexandra M.
    Neuner, Sarah
    Dunn, Amy
    Onos, Kristen D.
    Wiley, Jesse
    Archer, Derek
    Huentelman, Matthew J.
    Arnold, Matthias
    Menon, Vilas
    Goate, Alison
    Van Eldik, Linda J.
    Territo, Paul R.
    Howell, Gareth R.
    Carter, Gregory W.
    O'Connell, Kristen M. S.
    Kaczorowski, Catherine C.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (01)